121629-14-9 Usage
Uses
Used in Pharmaceutical Industry:
Cyclohexanecarboxylic acid, 4,4-difluoro-, methyl ester is used as an intermediate in the synthesis of new drugs for various medical conditions. Its unique chemical properties contribute to the development of innovative pharmaceutical compounds, enhancing treatment options for patients.
Used in Agrochemical Synthesis:
In the agrochemical industry, Cyclohexanecarboxylic acid, 4,4-difluoro-, methyl ester is utilized as a building block for the production of agricultural chemicals. Its role in the synthesis process aids in the creation of effective compounds for crop protection and other agricultural applications.
Used in Specialty Chemicals Production:
Cyclohexanecarboxylic acid, 4,4-difluoro-, methyl ester is also employed in the synthesis of specialty chemicals, where its unique properties are leveraged to produce compounds with specific applications in various industries, further demonstrating its versatility in organic chemistry.
Used in Research and Development:
As a key intermediate, Cyclohexanecarboxylic acid, 4,4-difluoro-, methyl ester is used in research and development to explore its potential applications and to create new organic compounds. Its presence in the lab setting facilitates advancements in the field of organic chemistry and contributes to the discovery of novel uses for Cyclohexanecarboxylic acid, 4,4-difluoro-, methyl ester.
Check Digit Verification of cas no
The CAS Registry Mumber 121629-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,6,2 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 121629-14:
(8*1)+(7*2)+(6*1)+(5*6)+(4*2)+(3*9)+(2*1)+(1*4)=99
99 % 10 = 9
So 121629-14-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H12F2O2/c1-12-7(11)6-2-4-8(9,10)5-3-6/h6H,2-5H2,1H3
121629-14-9Relevant academic research and scientific papers
TRICYCLIC COMPOUND SERVING AS IMMUNOMODULATOR
-
Paragraph 0298-0299, (2019/01/04)
Provided are compounds of formula I and formula II or pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. The compounds of formula I and formula II or the pharmaceutically acceptable salts of the compounds provide indole 2,3-dioxygenase (IDO) inhibitory activity and are capable of treating IDO-mediated immunosuppressive diseases, such as infectious diseases or cancer.
CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS
-
Page/Page column 44-45, (2012/03/26)
The invention relates to the cycloalkyl methoxybenzyl phenyl pyran derivatives as Sodium dependent glucose co transporter (SGLT) inhibitors, particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 with them, and processes for preparing them.
Fluorinated carbocylic compounds
-
, (2008/06/13)
Fluoro-substituted carbocyclic compounds are prepared by (A) reacting hydrogen fluoride with a chloro-cyclohexenyl compound of the formula STR1 where R1 and R2 are independently selected from the group consisting of --H, --CH2 OH, --COF, --COCl, --CF3, --CN, STR2 and --CH2 R, where R is --H or alkyl of 1-4 carbon atoms, to form a gem-dihalocyclohexane compound of the formula STR3 where X is chlorine and R1 and R2 are as defined above, (B) dehydrohalogenating the gem-dihalocyclohexane compound in the vapor phase to form a fluoro-cyclohexenyl compound of the formula STR4 (C) contacting the fluoro-cyclohexenyl compound, in the vapor phase, with a dehydrogenation catalyst to form a fluoro-substituted aromatic compound of the formula STR5
